Skip to main content
Tech.euFundingExplorerBeta
Funding rounds/Oxford Drug Design

Oxford Drug Design

Other
Oxford, UKMay 2022
Healthtech

Oxford Drug Design raised €2.6M in a funding round in May 2022. The company is based in Oxford, UK. Investors in the round: ACF investors, Meltwind Advisory LLP, o2h Ventures and 1 other. Data as of Nov 2026.

← Oxford Drug Design
Amount raised
€2.6M
€2,596,544
Native amount
2,200,000 GBP
Stage
Other
funding round
Investors
4

Provenance & confidence

High confidence
Amount
2,200,000 GBP
ECB-at-date → €2.6M · rate 0.84728 on 2022-05-19
High confidence
Source

businesscloud.co.uk · established

High confidence

Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.

Investors in this round

4 named
ACF investorsMeltwind Advisory LLPo2h VenturesR42 Group
Date
May 2022
Round type
funding round
Amount (EUR)
€2.6M

Other rounds

same company

This is the company's only recorded round.

Related news